OECD proposes new rules for multinational drug studies

02/27/2013 | PharmaTimes (U.K.)

The Organization for Economic Co-operation and Development has called on member nations to harmonize their rules for risk management of multinational clinical trials run by universities, hospitals and other nonprofit organizations. Such noncommercial drug trials increasingly involve study sites in multiple countries, and differing national regulations can raise barriers and costs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL